🔗 Permalink

Assignee profile:

Immatics Biotechnologies GmbH

City:

Country:

Germany

Published Applications:

Last publication date:

2023-08-03

Patent Grants:

Last grant date:

2024-05-21

Top Inventors for applications by Immatics Biotechnologies GmbH

These are the the leading inventors for applications assigned to Immatics Biotechnologies GmbH:

Oliver SCHOOR 21 Tuebingen, Germany
Andrea Mahr 19 Tuebingen, Germany
Toni WEINSCHENK 18 Tuebingen, Germany
Jens Fritsche 17 Tuebingen, Germany

Harpreet Singh 16 Tuebingen, Germany
Toni WEINSCHENK 12 Aichwald, Germany
Harpreet SINGH 10 Munich, Germany
Harpreet SINGH 10 Muenchen, Germany

Jens FRITSCHE 10 Dusslingen, Germany
Colette SONG 4 Tuebingen, Germany
Phillip Mueller 4 Tuebingen, Germany
Colette SONG 4 Ostfildern, Germany

Heiko SCHUSTER 4 Tuebingen, Germany
Anita WIEBE 3 Tuebingen, Germany
Peter Lewandrowski 3 Tuebingen-Hirschau, Germany
Julia LEIBOLD 3 Tuebingen, Germany

Steffen WALTER 2 Reutlingen, Germany
Daniel Johannes KOWALEWSKI 2 Tuebingen, Germany
Valentina GOLDFINGER 2 Tuebingen, Germany
Steffen WALTER 2 Houston, TX United States

Sarah KUTSCHER 2 Tuebingen, Germany
Helen HOERZER 2 Tuebingen, Germany
Lea Stevermann 2 Aachen, Germany
Steffen WALTER 2 Tuebingen, Germany

Hans Georg RAMMENSEE 2 Tuebingen, Germany
Philipp WAGNER 1 Tuebingen, Germany
Norbert HILF 1 Tuebingen, Germany
Anita WIEBE 1 Ruebgarten, Germany

Gisela SCHIMMACK 1 Tuebingen, Germany
Cecile Gouttefangeas 1 Tuebingen, Germany
Kevin Roehle 1 Tuebingen, Germany
Claudia TRAUTWEIN 1 Tuebingen, Germany

Janet PEPER 1 Tuebingen, Germany
Lea STEVERMANN 1 Tuebingen, Germany
Colette Song 1 Ostildern, Germany
Peter LEWANDROWSKI 1 Tuebingen, Germany

Michael ROEMER 1 Tuebingen, Germany
Stefan Stevanovic 1 Tuebingen, Germany
Linus BACKERT 1 Tuebingen, Germany
Daniel Johannes KOWALEWSKI 1 Kirchentellinsfurt, Germany

Recent patent applications by Immatics Biotechnologies GmbH

Immatics Biotechnologies GmbH based in , DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-03 ✅ Patent 11,986,497 granted on 2024-05-21

US20230241111A1

Human necessities

Immunotherapy against neuronal and brain tumors

#2 | 2023-06-15 ✅ Patent 11,957,742 granted on 2024-04-16

US20230181707A1

Human necessities

Method for treating non-small lung cancer with a population of activated T cells

#3 | 2023-01-12 ✅ Patent 12,065,471 granted on 2024-08-20

US20230012265A1

Chemistry; metallurgy

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#4 | 2023-01-05 ✅ Patent 12,065,477 granted on 2024-08-20

US20230002474A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#5 | 2022-11-10 ✅ Patent 12,150,979 granted on 2024-11-26

US20220356220A1

Chemistry; metallurgy

Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers

#6 | 2022-10-06 ✅ Patent 12,036,271 granted on 2024-07-16

US20220313807A1

Human necessities

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#7 | 2022-09-08 ✅ Patent 11,939,401 granted on 2024-03-26

US20220281917A1

Chemistry; metallurgy

Immunotherapy against several tumors including lung cancer

#8 | 2022-08-11 ✅ Patent 12,029,785 granted on 2024-07-09

US20220249630A1

Human necessities

GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers

#9 | 2022-07-21 ✅ Patent 11,951,160 granted on 2024-04-09

US20220226451A1

Human necessities

Peptides and T cells for use in immunotherapeutic treatment of various cancers

#10 | 2022-06-23 ✅ Patent 11,939,400 granted on 2024-03-26

US20220194984A1

Chemistry; metallurgy

Immunotherapy against several tumors including lung cancer

#11 | 2022-06-09 ✅ Patent 12,023,372 granted on 2024-07-02

US20220175898A1

Human necessities

Peptides and T cells for use in immunotherapeutic treatment of various cancers

#12 | 2022-05-12 ✅ Patent 12,144,852 granted on 2024-11-19

US20220143164A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#13 | 2022-04-28 ✅ Patent 12,076,381 granted on 2024-09-03

US20220125902A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#14 | 2022-03-03 ✅ Patent 12,071,458 granted on 2024-08-27

US20220064241A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#15 | 2022-02-24 ✅ Patent 12,005,105 granted on 2024-06-11

US20220054612A1

Human necessities

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#16 | 2022-02-10 ✅ Patent 11,965,013 granted on 2024-04-23

US20220041690A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#17 | 2022-02-10 ✅ Patent 12,064,465 granted on 2024-08-20

US20220040259A1

Human necessities

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#18 | 2022-01-27 ✅ Patent 12,070,491 granted on 2024-08-27

US20220023403A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

#19 | 2022-01-20 ✅ Patent 12,006,349 granted on 2024-06-11

US20220017595A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#20 | 2022-01-20 ✅ Patent 12,076,380 granted on 2024-09-03

US20220016227A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

#21 | 2022-01-06 ✅ Patent 12,018,064 granted on 2024-06-25

US20220002378A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#22 | 2022-01-06 ✅ Patent 12,084,486 granted on 2024-09-10

US20220002374A1

Chemistry; metallurgy

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

#23 | 2021-11-11 ✅ Patent 11,975,042 granted on 2024-05-07

US20210346466A1

Human necessities

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#24 | 2021-10-28 ✅ Patent 12,076,379 granted on 2024-09-03

US20210330771A1

Human necessities

A*03 restricted peptides for use in immunotherapy against cancers and related methods

#25 | 2021-10-28 ✅ Patent 11,969,455 granted on 2024-04-30

US20210330743A1

Human necessities

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#26 | 2021-09-23 ✅ Patent 12,084,522 granted on 2024-09-10

US20210292367A1

Chemistry; metallurgy

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#27 | 2021-09-09 ✅ Patent 11,999,774 granted on 2024-06-04

US20210277087A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#28 | 2021-09-09 ✅ Patent 11,912,748 granted on 2024-02-27

US20210277081A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#29 | 2021-09-09 ✅ Patent 11,938,176 granted on 2024-03-26

US20210275652A1

Human necessities

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#30 | 2020-04-02 ✅ Patent 11,988,669 granted on 2024-05-21

US20200103408A1

Physics

Method for the absolute quantification of naturally processed hla-restricted cancer peptides

#31 | 2020-03-12 ✅ Patent 11,957,729 granted on 2024-04-16

US20200078439A1

Human necessities

Powerful MHC-class II peptides derived from survivin

AssigneeID:

608865 ⎘